via Bloomberg Business
A Bloomberg News analysis finds that even after these discounts, prices are higher in the U.S. than abroad. Seven of eight top-selling drugs examined still cost more in the U.S. than most other countries.
Bloomberg estimated the actual amounts that drug manufacturers are paid on a sample of top-selling drugs. SSR Health, an investment research firm, used prescription data and U.S. list prices to determine the drugs’ sales in the country before discounts. To approximate the discounts, SSR Health subtracted the actual U.S. sales reported by the companies. Bloomberg compared the discounted monthly prices with list prices from 14 countries, using local data from IHS Inc., a data analysis and consulting firm, and other sources.